A practical MCP security benchmark for 2026: scoring model, risk map, and a 90-day hardening plan to prevent prompt injection, secret leakage, and permission abuse.
Avonex is a prescription drug that treats relapsing forms of multiple sclerosis (MS) in adults, such as relapsing-remitting MS, active secondary progressive MS, and clinically isolated syndrome.